Close Menu

NEW YORK — The US Food and Drug Administration on Friday granted Emergency Use Authorization for a PCR-based SARS-CoV-2 test developed at George Washington University.

The GWU COVID-19 RT-PCR test is designed to detect the SARS-CoV-2 N gene in upper respiratory specimens and bronchoalveolar lavage. Nucleic extraction is performed using Thermo Fisher Scientific's MagMax-96 Viral RNA Isolation Kit on Hamilton's Microlab STAR Liquid Handling System, and the test runs on the Roche LightCycler 480 instrument.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Sponsored by
LGC SeraCare Life Sciences

Non-invasive prenatal testing (NIPT) continues to expand globally to support maternal-fetal patient care. 

Sponsored by

As cases of COVID-19 continued to grow this spring and summer in the US, so too did the number of Emergency Use Authorizations from the FDA for clinical diagnostic tests aimed at detecting current and past infections.